Results 161 to 170 of about 3,367,821 (256)

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Blood, 2008
D. Rollison, N. Howlader, Martyn T. Smith, S. Strom, W. Merritt, L. Ries, B. Edwards, A. List   +7 more
semanticscholar   +1 more source

Four Cases of Myeloproliferative Disorders Associated With Down Syndrome: Distinguishing ML-DS From TAM-DS: Distinguishing TAM-DS and ML-DS: Report of 4 Cases. [PDF]

Case Rep Hematol
Boumeghar K, Daliphard S, Buchbinder N, Boutet C, Penther D, Etancelin P, Bourgain J, Buchonnet G, Bera E, Bobée V.   +9 more
europepmc   +1 more source

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population. [PDF]

Asian Pac J Cancer Prev, 2019
Syeed N.
europepmc   +1 more source

Pairing JAK with MEK for improved therapeutic efficiency in myeloproliferative disorders. [PDF]

J Clin Invest, 2019
Williams DA.
europepmc   +1 more source

Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders. [PDF]

Clin Appl Thromb Hemost, 2018
Yildiz A, Güryildirim M, Pepeler MS, Yazol M, Oktar SÖ, Acar K.   +5 more
europepmc   +1 more source

Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders. [PDF]

J Natl Compr Canc Netw, 2017
McFarland DC, Shaffer KM, Polizzi H, Mascarenhas J, Kremyanskaya M, Holland J, Hoffman R.   +6 more
europepmc   +1 more source

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

Blood, 2005
D. Steensma, G. Dewald, T. Lasho, H. Powell, R. Mcclure, Ross L. Levine, D. Gilliland, A. Tefferi   +7 more
semanticscholar   +1 more source

Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

Genes & cancer, 2010
Shashidhar S. Jatiani, S. Baker, L. Silverman, E. Reddy   +3 more
semanticscholar   +1 more source

Myocardial infarction as a thrombotic complication of myeloproliferative disorders. [PDF]

Anatol J Cardiol, 2016
Petrou E, Karali V.
europepmc   +1 more source

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. [PDF]

Blood Adv, 2018
Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A.   +24 more
europepmc   +1 more source